We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU

By HospiMedica International staff writers
Posted on 17 Mar 2026

Neonatal sepsis remains a leading cause of death in low- and middle-income countries, where overcrowded facilities and limited resources heighten transmission risks from multidrug-resistant pathogens. More...

Klebsiella pneumoniae is a frequent cause of bloodstream infections in these settings, complicating rapid diagnosis and treatment. Practical, low-cost prevention strategies are needed to interrupt spread within neonatal intensive care units. A new study shows that a multifaceted infection prevention approach can temporarily disrupt K. pneumoniae transmission in a high-burden setting.

Boston University School of Public Health (BUSPH) and the London School of Hygiene & Tropical Medicine (LSHTM) evaluated a bundle of infection prevention and control (IPC) measures alongside whole-genome sequencing (WGS) to investigate a prolonged K. pneumoniae outbreak in a Zambian neonatal intensive care unit. WGS—the gold standard for bacterial identification—was used to delineate transmission patterns and outbreak dynamics. The analysis found that the IPC bundle successfully interrupted a large, long-running outbreak but did not eradicate transmission entirely. 

The IPC bundle, implemented over 12 months, comprised staff IPC training, text message reminders of key practices, onsite production of World Health Organization–formulated alcohol hand rub, enhanced unit-wide cleaning, and weekly bathing of newborns with 2% chlorhexidine gluconate. Using blood samples collected during the Sepsis Prevention in Neonates in Zambia (SPINZ) study, investigators applied WGS to 411 K. pneumoniae isolates to track development and spread of strains before and after the interventions. Neonatal mortality was lower during the IPC intervention period.

While initial transmission was contained, some bacteria reemerged and new strains appeared, leading to additional infections. Most tested isolates produced extended-spectrum beta-lactamases (ESBLs), conferring resistance to penicillin and other common antibiotics, and a few carbapenemases were detected, indicating resistance to last-resort carbapenems. Notably, nearly 35% of K. pneumoniae infections occurred within 2448 hours of admission, and most infections likely originated from contaminated sources within the unit rather than from outside the hospital.

Published in PLOS Global Public Health, the findings underscore the value of continued IPC programs and whole-genome surveillance in resource-limited hospitals to mitigate pathogen spread. The authors note that carbapenem resistance is already emerging in countries such as India and Thailand, narrowing therapeutic options and heightening the importance of prevention. The original evaluation of the IPC interventions in SPINZ was published in Clinical Infectious Diseases in 2019. 

“Neonatal sepsis is one of the major causes of death among children in the first 28 days of life. In low- and middle-income countries, the quality of infection prevention and control measures can be very limited and, as a result, there is a lot of cross-transmission from infected equipment or healthcare workers. Our study found that a variety of preventive measures worked to temporarily clear the main serotype while concurrently decreasing neonatal mortality, suspected sepsis, and confirmed bloodstream infections with true pathogens,” said Davidson Hamer, professor of global health and medicine at SPH and BU Chobanian & Avedisian School of Medicine.

Related Links
Boston University School of Public Health
London School of Hygiene & Tropical Medicine


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.